Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Although pancreatic ductal adenocarcinoma (PDA) is one of the most aggressive solid tumours, it is not genetically homogeneous. While Molecular PDA subtypes have been proposed but are not yet driving clinical treatment decision-making, we know that the tumour microenvironment plays a significant role in the progression and response to chemotherapy.